[
  {
    "ts": "2025-12-24T05:12:26+00:00",
    "headline": "Edwards Lifesciences (EW): Assessing Valuation After Recent Share Price Strength",
    "summary": "Edwards Lifesciences (EW) has been quietly rewarding patient investors, with shares up about 15% over the past 3 months and roughly 19% year to date, outpacing many large-cap healthcare peers. See our latest analysis for Edwards Lifesciences. At around $86.23 per share, Edwards Lifesciences has seen its recent share price returns strengthen, with the solid 90 day share price return hinting that investors are growing more comfortable with its growth profile despite a softer 5 year total...",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-assessing-valuation-051226927.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "70872d11-8052-34cc-b899-359b605d2a6c",
      "content": {
        "id": "70872d11-8052-34cc-b899-359b605d2a6c",
        "contentType": "STORY",
        "title": "Edwards Lifesciences (EW): Assessing Valuation After Recent Share Price Strength",
        "description": "",
        "summary": "Edwards Lifesciences (EW) has been quietly rewarding patient investors, with shares up about 15% over the past 3 months and roughly 19% year to date, outpacing many large-cap healthcare peers. See our latest analysis for Edwards Lifesciences. At around $86.23 per share, Edwards Lifesciences has seen its recent share price returns strengthen, with the solid 90 day share price return hinting that investors are growing more comfortable with its growth profile despite a softer 5 year total...",
        "pubDate": "2025-12-24T05:12:26Z",
        "displayTime": "2025-12-24T05:12:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9u7koo0rZkPGzBeI1l4rsQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5J1KBMD97NZX1sIZ71qfPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/0ce3c3847d701ab519c25ddde4a069d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-assessing-valuation-051226927.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-ew-assessing-valuation-051226927.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]